PDS Biotechnology Corp Temporary Equity, Dividends, Adjustment
PDS Biotechnology Corp (PDSB) reported Temporary Equity, Dividends, Adjustment of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TemporaryEquityDividendsAdjustment · last filed 2018-03-01
- PDS Biotechnology Corp temporary equity, dividends, adjustment for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp temporary equity, dividends, adjustment for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp temporary equity, dividends, adjustment for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp temporary equity, dividends, adjustment for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp temporary equity, dividends, adjustment for fiscal 2017 was $0.00.
- PDS Biotechnology Corp temporary equity, dividends, adjustment for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- PDS Biotechnology Corp temporary equity, dividends, adjustment for fiscal 2015 was $4.36M, a 175.60% increase from fiscal 2014.
- PDS Biotechnology Corp temporary equity, dividends, adjustment for fiscal 2014 was $1.58M, a 46.87% increase from fiscal 2013.
| Period end | Temporary Equity, Dividends, Adjustment 3 month | Temporary Equity, Dividends, Adjustment 6 month | Temporary Equity, Dividends, Adjustment 9 month | Temporary Equity, Dividends, Adjustment 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-01 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $0.00 10-Q · filed 2016-11-01 | $99.33K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-03 | $0.00 10-Q · filed 2016-08-03 | $99.33K derived: sum of 3 quarters · filed 2018-03-01 | $1.93M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-03 | $99.33K derived: sum of 2 quarters · filed 2018-03-01 | $1.93M derived: sum of 3 quarters · filed 2018-03-01 | $3.67M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $99.33K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.93M derived: sum of 2 quarters · filed 2018-03-01 | $3.67M derived: sum of 3 quarters · filed 2018-03-01 | $4.36M 10-K · filed 2018-03-01 |
| 2015-09-30 | $1.83M 10-Q · filed 2016-11-01 | $3.57M derived: sum of 2 quarters · filed 2016-11-01 | $4.26M 10-Q · filed 2016-11-01 | $4.76M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $1.75M 10-Q · filed 2016-08-03 | $2.43M 10-Q · filed 2016-08-03 | $2.93M derived: sum of 3 quarters · filed 2017-03-02 | $3.29M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-03-31 | $683.18K 10-Q · filed 2016-05-03 | $1.18M derived: sum of 2 quarters · filed 2017-03-02 | $1.55M derived: sum of 3 quarters · filed 2017-03-02 | |
| 2014-12-31 | $498.59K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $863.26K derived: sum of 2 quarters · filed 2017-03-02 | $1.58M 10-K · filed 2017-03-02 | |
| 2014-09-30 | $364.67K 10-Q · filed 2015-11-06 | $1.08M 10-Q · filed 2015-11-06 | ||
| 2013-12-31 | $1.08M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |